5 Policy Changes to Transform Public Safety that are not “Defund the Police”

As we’ve grappled with recent discourse around solutions to the epidemic of police violence that overwhelmingly affects people of color, we—as the leadership of Dr. Bronner’s—have discussed whether “Defund the Police” is the right message for our company. What does “Defund the Police” mean exactly? How will it be interpreted by our customers? Is there consensus within the company around “Defund the Police” as a policy and message?

Continue Reading

Psychedelics at a Crossroads: We Need Constructive Not Extractive Capital

In her recent thoughtful and well-researched article for Vice, Shayla Love asked, “Is it possible to create an ethical psychedelics company?” A lot of focus in the psychedelics space over the last few months has centered around the unethical behavior of select companies—David himself has weighed in. Our take is that it’s not only possible to create an ethical psychedelics company,

Continue Reading

Acting Against Hate Towards Asian-Americans and Pacific Islanders

This statement was initiated by Asian-American and Pacific Islander (AAPI)  employees at Dr. Bronner’s along with our BIPOC (Black, Indigenous, and People of Color) taskforce. Reports of anti-Asian hate crimes rose nearly 150% in America’s largest cities last year, reflecting a growing trend of discrimination against Asian-Americans and Pacific Islanders during the Covid-19 pandemic. This week alone,

Continue Reading

Sounding the Alarm on Compass’s Interference with Oregon’s Psilocybin Therapy Program

It’s time to publicly call out the for-profit psychedelic pharma company Compass Pathways, for their monopolistic and shady behavior. This Vice article, “Can a Company Patent the Basic Components of Psychedelic Therapy”, details their recent attempts to patent a clinical setting with mood lighting, soft furniture, subdued colors and a good sound system. This was after they tried to patent psilocybin synthesis in a way that would occupy the field and prevent awesome nonprofit drug development companies like Usona and B-more,

Continue Reading

The Unified Field Theory of Psychedelic Integration and Portugal Style Decriminalization

How non-profit psychedelic drug development harmonizes with efforts to decriminalize plant medicines and legalize psilocybin therapy for all; and how all support broad-based Portugal style decriminalization This article, recently published in the 2020 MAPS Spring Bulletin, discusses key strategies in motion to mainstream access to psychedelic medicine and therapy in the U.S.. To introduce the topic in the context of the 50th anniversary of Earth Day and the urgent climate change crisis we face,

Continue Reading

Dr. Bronner’s Supports the Green New Deal

The United Nations 2019 Climate Gap Emissions Report laid bare the stark reality of the climate crisis. 27 years after the Kyoto Protocol that committed nations to reducing greenhouse gas (GHG) emissions, GHG emissions have actually increased. 2019 represented a critical milestone in the global climate crisis—it marked the hottest year on record in the northern hemisphere.

Continue Reading

Fair Trade Supports Climate Solutions

In 2014, the U.N. reported that at current erosion rates, less than 60 years of farmable soil remains on our planet before we lose this precious living membrane to wind and water erosion. Meanwhile, increasing temperatures are causing more frequent and severe climate catastrophes. No one is immune to the global climate crisis, but those least responsible for human-caused climate change are often the most severely impacted.

Continue Reading

Why We Support the 2020 Ballot Measure that Would Legalize & Regulate Psilocybin Therapy in Oregon

Dr. Bronner’s Donates $150,000 in Matching Funds to Support Signature Drive Last night it was my honor to join Tom and Sheri Eckert, experienced Portland-based therapists who are the chief petitioners for Oregon’s statewide ballot initiative to legalize psilocybin-assisted therapy, as they welcomed famed mycologist Paul Stamets and special guests for an event at the Newmark Theatre in Portland.

Continue Reading